Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
6.27
+0.37 (6.27%)
At close: Jan 22, 2026, 4:00 PM EST
6.38
+0.11 (1.75%)
After-hours: Jan 22, 2026, 7:57 PM EST
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $1.12 billion as of January 22, 2026. Its market cap has increased by 419.57% in one year.
Market Cap
1.12B
Enterprise Value
905.17M
1-Year Change
419.57%
Ranking
Category
Stock Price
$6.27
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has increased from $435.34M to $1.12B, an increase of 156.17%. That is a compound annual growth rate of 21.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.05B | 9.87% |
| Dec 31, 2025 | 955.12M | 378.75% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | 435.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palvella Therapeutics | 1.11B |
| Inhibrx Biosciences | 1.09B |
| Aktis Oncology | 1.07B |
| Phathom Pharmaceuticals | 1.07B |
| Zenas BioPharma | 1.05B |
| Theravance Biopharma | 1.03B |
| ARS Pharmaceuticals | 1.03B |
| Annexon | 1.02B |